Skip to content

Capiox® FX Hollow Fiber Oxygenator w Integrated Arterial Filter w Hardshell Res. 3CX*FX15RW30Recalls & reported problems

Terumo Cardiovascular Systems Corporation · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00699753450745), received between Dec 23, 2019 and Dec 23, 2019 — classified as 1 malfunction.

The most frequently reported specific device problem is “Infusion or Flow Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Infusion or Flow Problem1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 23, 2019Infusion or Flow Problem; Infusion or Flow Problem

    THE USER FACILITY REPORTED TO TERUMO CARDIOVASCULAR THAT DURING CARDIOPULMONARY BYPASS, THERE WAS AN IMPEDED VENOUS RETURN OF THE RESERVOIR. THE RESERVOIR WAS CAUSING BACK PRESSURE INTO THE VENOUS SIDE OF THE MANIFOLD. SUFFICIENT FLOW WAS ABLE TO BE MAINTAINED FOR THE PATIENT BUT WERE LIMITED TO 2.4 LPM. NO KNOWN IMPACT OR CONSEQUENCE TO PATIENT. THE PRODUCT WAS NOT CHANGED OUT. THE SURGERY WAS COMPLETED SUCCESSFULLY.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 9512110 ↗

Other Oxygenator, Cardiopulmonary Bypass devices

All Oxygenator, Cardiopulmonary Bypass devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page